Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent
10.9758/cpn.2019.17.3.450
- Author:
Jong Il PARK
1
;
Tae Won PARK
Author Information
1. Department of Psychiatry, Chonbuk National University Medical School, Jeonju, Korea. ptaewon@jbnu.ac.kr
- Publication Type:Case Report
- Keywords:
Neuroleptic malignant syndrome;
Rhabdomyolysis;
Risperidone
- MeSH:
Adolescent Psychiatry;
Adolescent;
Adult;
Antipsychotic Agents;
Child;
Drug-Related Side Effects and Adverse Reactions;
Humans;
Neuroleptic Malignant Syndrome;
Rhabdomyolysis;
Risperidone
- From:Clinical Psychopharmacology and Neuroscience
2019;17(3):450-452
- CountryRepublic of Korea
- Language:English
-
Abstract:
Along with the field of adult psychiatry, antipsychotic agents are increasingly used in the field of child and adolescent psychiatry. Although neuroleptic malignant syndrome (NMS) and rhabdomyolysis are rare complication associated with antipsychotic agent, clinicians should need to pay attention to all potential adverse drug reaction (ADR). Also, ADRs in child and adolescent could show different signs and symptoms compared with those in adult. In this case report, we present a case of NMS in a child which occurred shortly after the resolution of rhabdomyolysis which was induced by low-dose risperidone.
